Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NAVI


Fundamental

Company: Navient Corp
Sector: Financial
Industry: Credit Services
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.53
Insider Own: 2.47%
Shs Outstand: 97.51M
Perf Week: 2.78%
Market Cap: 1.19B
Forward P/E: 10.27
EPS next Y: 1.19
Insider Trans: 0.00%
Shs Float: 95.10M
Perf Month: -2.00%
Enterprise Value: 45.65B
PEG: -
EPS next Q: 0.31
Inst Own: 104.64%
Short Float: 8.01%
Perf Quarter: -7.07%
Income: -50.00M
P/S: 0.35
EPS this Y: -94.19%
Inst Trans: -0.59%
Short Ratio: 9.82
Perf Half Y: -11.06%
Sales: 3.41B
P/B: 0.49
EPS next Y Percentage: 923.52%
ROA: -0.10%
Short Interest: 7.61M
Perf YTD: -8.05%
Book/sh: 25.01
P/C: 0.64
EPS next 5Y: -10.22%
ROE: -1.95%
52W High: 16.07 -23.96%
Perf Year: -18.97%
Cash/sh: 19.20
P/FCF: 4.33
EPS past 3/5Y: -34.34% -14.36%
ROIC: -0.11%
52W Low: 10.53 16.05%
Perf 3Y: -20.70%
Dividend Est.: 0.64 (5.24%)
EV/EBITDA: 15.52
Sales past 3/5Y: 6.59% -4.95%
Gross Margin: 91.62%
Volatility W: 2.04%
Volatility M: 2.82%
Perf 5Y: 30.14%
Dividend TTM: 0.64 (5.24%)
EV/Sales: 13.38
EPS Y/Y TTM: -174.34%
Oper. Margin: 77.88%
ATR (14): 0.35
Perf 10Y: -8.87%
Dividend Ex-Date: Sep 05, 2025
Quick Ratio: 0.72
Sales Y/Y TTM: -25.22%
Profit Margin: -1.46%
RSI (14): 48.86
Recom: 3.30
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 0.72
EPS Q/Q: -4643.78%
SMA20: 0.03%
Beta: 1.31
Target Price: 13.00
Payout: 54.23%
Debt/Eq: 19.00
Sales Q/Q: -19.92%
SMA50: -3.56%
Rel Volume: 0.85
Prev Close: 11.78
Employees: 2100
LT Debt/Eq: 16.98
Earnings: Oct 29 BMO
SMA200: -7.26%
Avg Volume: 775.37K
Price: 12.22
IPO: Apr 17, 2014
Option/Short: Yes / Yes
EPS/Sales Surpr.: -570.85% -2.17%
Trades:
Volume: 657,090
Change: 3.74%

Technical:


Latest News:

Nvidia stock is navigating one of its most turbulent weeks ever - Quartz somewhat bearish
NVDA

Summary: Nvidia stock is navigating one of its most turbulent weeks ever

Full article
2024-09-06T17:09:23Z
Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak - Yahoo Movies UK neutral
MYL.O PFE.N

Summary: Mylan NV's merger with Pfizer's off-patent branded drug unit, Upjohn, will close in the second half of this year due to delays caused by the coronavirus pandemic. The merger is part of Pfizer's effort to split into three parts - innovative medicines, off-patent drugs, and consumer healthcare.

Full article
2024-05-29T06:45:52Z
How Home Depot & Lowe's plan to navigate DIY drop-off - Modern Retail somewhat bearish
HD LOW

Summary: Both Home Depot and Lowe’s reported drops in year-over-year sales as shoppers pulled back on home improvement spending. To overcome the challenging environment, the chains are focusing on catering to professional contractors and enhancing online customer experience. Despite the decreases in foot traffic and softer market for larger-ticket purchases, they are looking at potential growth opportunities by expanding services for contractors and driving online sales.

Full article
2024-05-22T04:03:39Z
VERITAS study shows Medtronic fluoroscopic navigation platform offers a safer lung biopsy ... neutral
MDT

Summary: Medtronic plc is a global leader in medical equipment design, manufacturing, and marketing, with net sales across various sectors including surgery, cardiac rhythm management, vascular diseases, and more. The company also distributes its products geographically with a significant presence in the United States.

Full article
2024-05-21T23:54:53Z
VERITAS study shows Medtronic fluoroscopic navigation platform offers a safer lung biopsy ... neutral
MDT

Summary: Medtronic announced new preliminary data from the VERITAS clinical study showing its ENB platform is non-inferior to CT-guided biopsy for diagnosing lung nodules, with reduced procedure-related complications. The study demonstrated ENB was diagnostic in 76% of patients and had significantly fewer complications compared to CT-guided biopsy.

Full article
2024-05-21T23:38:28Z
MetLife's (MET) My Leave Navigator to Boost Leave Experience | Nasdaq somewhat bullish
MET AMBC BRO ROOT

Summary: MetLife, Inc. introduced a new digital tool called My Leave Navigator to support employees in pre-leave planning and accessing employer-sponsored programs. The tool aims to increase confidence and awareness of available benefits, ultimately enhancing employee loyalty and productivity. MetLife's shares have outperformed the industry with a 39.2% gain in the past year.

Full article
2024-05-21T18:46:31Z
MetLife's (MET) My Leave Navigator to Boost Leave Experience - Yahoo Finance somewhat bullish
MET BRO AMBC ROOT

Summary: MetLife, Inc. introduced a new digital tool, My Leave Navigator, to enhance employee experience and provide support during leave due to various life events. The company's research shows high demand for such services. MetLife's shares have gained 39.2% in the past year, outperforming the industry.

Full article
2024-05-21T18:08:59Z
Apple and Île-de-France Mobilités introduce Navigo card for iPhone and Apple Watch neutral
AAPL

Summary: Apple and Île-de-France Mobilités have introduced a Navigo card for iPhone and Apple Watch, providing an easy and secure way for customers to pay for transit in the Paris region. Real-time transit information in Apple Maps is also launched for users in Paris.

Full article
2024-05-21T16:14:53Z
MetLife launches My Leave Navigator neutral
MET

Summary: MetLife introduced My Leave Navigator, a digital offering to aid employees in planning time off due to disability or other events, providing customized guidance and enhancing confidence in managing leave.

Full article
2024-05-20T13:57:16Z
MetLife Launches My Leave Navigator to Support Employees Navigating Leave | Morningstar neutral
MET

Summary: MetLife launches My Leave Navigator to support employees navigating leave, a new holistic digital experience to improve employee experience from pre-leave planning to claim submission and beyond.

Full article
2024-05-20T12:25:47Z
MetLife Launches My Leave Navigator to Support Employees Navigating Leave - Placera neutral
MET

Summary: MetLife introduces My Leave Navigator, a new digital solution to help employees plan time away due to a disability or event, providing intuitive guidance and support throughout the leave process.

Full article
2024-05-20T12:12:05Z
MetLife Launches My Leave Navigator to Support Employees Navigating Leave - Markets data neutral
MET

Summary: MetLife announced My Leave Navigator, a new digital offering to support employees planning time away from work due to a disability or event, providing intuitive guidance and boosting confidence. The offering helps individuals focus on life moments without worrying about the claims process, offering pre-leave planning, intuitive intake experience, and access to resources.

Full article
2024-05-20T12:08:26Z